Show
Sort by
-
Downregulation of the FTO m(6)A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors
-
Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis
-
- Journal Article
- A1
- open access
The tale of TILs in breast cancer : a report from the International Immuno-Oncology Biomarker Working Group
-
- Journal Article
- A1
- open access
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
-
- Journal Article
- A1
- open access
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
-
- Journal Article
- A1
- open access
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
-
- Journal Article
- A1
- open access
Pan-cancer analysis of whole genomes
-
- Journal Article
- A2
- open access
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
-
- Journal Article
- A1
- open access
Assessing tumor-infiltrating lymphocytes in solid tumors : a practical review for pathologists and proposal for a standardized method from the International Immunooncology Biomarkers Working Group, part 1 : assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research
-
Assessing tumor-infiltrating lymphocytes in solid tumors : a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group, part 2 : TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors
-
- Journal Article
- A1
- open access
Portraying breast cancers with long noncoding RNAs
-
Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS)
-
Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)